ATS 2019: Video 1 met dr. Paul Bresser, OLVG Amsterdam
May 2019
RA
ATS
nintedanib
SENSCIS Trial
instertitiële longziekten
Bresser
A7360: Nintedanib Reduces Lung Function Decline in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: Results of the SENSCIS Trial.
Longarts Dr. Paul Bresser longarts OLVG over de SENSCIS Trial:
Wilt u meer lezen? Log dan in.